S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Price, News & Analysis

$28.30
-0.04 (-0.14%)
(As of 02/23/2024 ET)
Today's Range
$27.98
$29.08
50-Day Range
$26.12
$35.39
52-Week Range
$23.10
$53.50
Volume
120,397 shs
Average Volume
148,580 shs
Market Capitalization
$660.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.50

OrthoPediatrics MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
50.2% Upside
$42.50 Price Target
Short Interest
Healthy
5.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
-0.34mentions of OrthoPediatrics in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$81,458 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($0.89) to ($0.96) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.12 out of 5 stars

Medical Sector

161st out of 936 stocks

Surgical & Medical Instruments Industry

20th out of 92 stocks


KIDS stock logo

About OrthoPediatrics Stock (NASDAQ:KIDS)

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

KIDS Stock Price History

KIDS Stock News Headlines

The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Best Mattresses for Kids in 2024
Brokerages Set OrthoPediatrics Corp. (NASDAQ:KIDS) PT at $42.50
OrthoPediatrics just downgraded at Truist, here's why
Decoding 5 Analyst Evaluations For OrthoPediatrics
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
The Best Kids Headphones
OrthoPediatrics: Q3 Earnings Snapshot
See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
2/25/2024
Next Earnings (Confirmed)
3/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:KIDS
Employees
203
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$42.50
High Stock Price Target
$52.00
Low Stock Price Target
$31.00
Potential Upside/Downside
+50.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$1.26 million
Pretax Margin
-15.69%

Debt

Sales & Book Value

Annual Sales
$122.29 million
Book Value
$16.54 per share

Miscellaneous

Free Float
15,740,000
Market Cap
$660.81 million
Optionable
Optionable
Beta
1.17
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives















KIDS Stock Analysis - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price target for 2024?

4 brokers have issued twelve-month target prices for OrthoPediatrics' shares. Their KIDS share price targets range from $31.00 to $52.00. On average, they predict the company's share price to reach $42.50 in the next year. This suggests a possible upside of 50.2% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2024?

OrthoPediatrics' stock was trading at $32.51 at the beginning of 2024. Since then, KIDS shares have decreased by 12.9% and is now trading at $28.30.
View the best growth stocks for 2024 here
.

Are investors shorting OrthoPediatrics?

OrthoPediatrics saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 829,700 shares, a decrease of 16.0% from the January 15th total of 987,600 shares. Based on an average daily volume of 165,300 shares, the days-to-cover ratio is currently 5.0 days. Approximately 5.3% of the company's shares are sold short.
View OrthoPediatrics' Short Interest
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 6th 2024.
View our KIDS earnings forecast
.

How can I listen to OrthoPediatrics' earnings call?

OrthoPediatrics will be holding an earnings conference call on Thursday, March 7th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) issued its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.13. The business earned $25.08 million during the quarter. OrthoPediatrics had a negative trailing twelve-month return on equity of 5.58% and a negative net margin of 15.57%.

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics updated its FY 2024 earnings guidance on Monday, January, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $197.0 million-$200.0 million, compared to the consensus revenue estimate of $177.7 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by a variety of institutional and retail investors. Top institutional investors include Brown Capital Management LLC (14.21%), Brown Advisory Inc. (6.98%), Braidwell LP (4.74%), Vanguard Group Inc. (3.74%), Granahan Investment Management LLC (3.29%) and New York State Common Retirement Fund (2.38%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KIDS) was last updated on 2/25/2024 by MarketBeat.com Staff